secwatch / observer
8-K filed June 25, 2024, 7:59 PM ET ticker GOCO CIK 0001808220
leadership confidence high sentiment neutral materiality 0.50

Director Joseph G. Flanagan resigns from GoHealth Board; Alexander Timm named lead independent director

GoHealth, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Joseph G. Flanagan

Director
GOCO · GoHealth, Inc.
Effective
2024-06-25
Filed
June 25, 2024, 7:59 PM ET
Joseph G. Flanagan, a member of the Board of Directors (the “Board”) of GoHealth, Inc. (the “Company”), informed the Company of his intent to resign from the Board effective June 25, 2024.
Role change

Alexander Timm

Lead Independent Director
GOCO · GoHealth, Inc.
Effective
2024-06-25
Filed
June 25, 2024, 7:59 PM ET
Alexander Timm will replace Mr. Flanagan as lead independent director.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Joseph G. Flanagan resigned as Director at GoHealth, Inc..

Action
resigned
Role
Director
Exact text from the filing
Joseph G. Flanagan, a member of the Board of Directors (the “Board”) of GoHealth, Inc. (the “Company”), informed the Company of his intent to resign from the Board effective June 25, 2024.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.9

Alexander Timm was appointed as Lead Independent Director at GoHealth, Inc..

Action
appointed
Role
Lead Independent Director
Exact text from the filing
Alexander Timm will replace Mr. Flanagan as lead independent director.
View on SEC.gov

GoHealth, Inc. filing history →

Source: SEC EDGAR
accession 0001808220-24-000074
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.